Hillard Weinstock1, Stuart Berman, Willard Cates. 1. Epidemiology and Surveillance Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. hsw2@cdc.gov
Abstract
CONTEXT: In the United States, young people aged 15-24 represent 25% of the sexually experienced population. However, the incidence and prevalence of sexually transmitted diseases (STDs) among this age-group are unknown. METHODS: Data from a variety of sources were used to estimate the incidence and prevalence of STDs among 15-24-year-olds in the United States in 2000. The quality and reliability of the estimates were categorized as good, fair or poor, depending on the quality of the data source. RESULTS: Approximately 18.9 million new cases of STD occurred in 2000, of which 9.1 million (48%) were among persons aged 15-24. Three STDs (human papillomavirus, trichomoniasis and chlamydia) accounted for 88% of all new cases of STD among 15-24-year-olds. CONCLUSIONS: These estimates emphasize the toll that STDs have on American youth. More representative data are needed to help monitor efforts at lowering the burden of these infections.
CONTEXT: In the United States, young people aged 15-24 represent 25% of the sexually experienced population. However, the incidence and prevalence of sexually transmitted diseases (STDs) among this age-group are unknown. METHODS: Data from a variety of sources were used to estimate the incidence and prevalence of STDs among 15-24-year-olds in the United States in 2000. The quality and reliability of the estimates were categorized as good, fair or poor, depending on the quality of the data source. RESULTS: Approximately 18.9 million new cases of STD occurred in 2000, of which 9.1 million (48%) were among persons aged 15-24. Three STDs (human papillomavirus, trichomoniasis and chlamydia) accounted for 88% of all new cases of STD among 15-24-year-olds. CONCLUSIONS: These estimates emphasize the toll that STDs have on American youth. More representative data are needed to help monitor efforts at lowering the burden of these infections.
Authors: Matthew B Schabath; Luisa L Villa; Eduardo Lazcano-Ponce; Jorge Salmerón; Manuel Quiterio; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-10-20 Impact factor: 4.254
Authors: Gabriel O Akogbe; Abidemi Ajidahun; Bradley Sirak; Gabriella M Anic; Mary R Papenfuss; William J Fulp; Hui-Yi Lin; Martha Abrahamsen; Luisa L Villa; Eduardo Lazcano-Ponce; Manuel Quiterio; Danelle Smith; Matthew B Schabath; Jorge Salmeron; Anna R Giuliano Journal: Int J Cancer Date: 2012-01-11 Impact factor: 7.396
Authors: Allecia E Reid; Urania Magriples; Linda M Niccolai; Derrick M Gordon; Anna A Divney; Trace S Kershaw Journal: Am J Community Psychol Date: 2013-06
Authors: Risa L Yavorsky; Dominic Hollman; John Steever; Christine Soghomonian; Angela Diaz; Howard Strickler; Nicolas Schlecht; Robert D Burk; Christopher N Ochner Journal: Clin Pediatr (Phila) Date: 2014-05-07 Impact factor: 1.168